105 related articles for article (PubMed ID: 16205116)
1. The Arf tumor suppressor regulates platelet-derived growth factor receptor beta signaling: a new view through the eyes of Arf(-/-) mice.
Thornton JD; Silva RL; Martin AC; Skapek SX
Cell Cycle; 2005 Oct; 4(10):1316-9. PubMed ID: 16205116
[TBL] [Abstract][Full Text] [Related]
2. Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.
Silva RL; Thornton JD; Martin AC; Rehg JE; Bertwistle D; Zindy F; Skapek SX
EMBO J; 2005 Aug; 24(15):2803-14. PubMed ID: 16037818
[TBL] [Abstract][Full Text] [Related]
3. p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.
Widau RC; Zheng Y; Sung CY; Zelivianskaia A; Roach LE; Bachmeyer KM; Abramova T; Desgardin A; Rosner A; Cunningham JM; Skapek SX
Mol Cell Biol; 2012 Nov; 32(21):4270-82. PubMed ID: 22907756
[TBL] [Abstract][Full Text] [Related]
4. miR-34a is essential for p19(Arf)-driven cell cycle arrest.
Iqbal N; Mei J; Liu J; Skapek SX
Cell Cycle; 2014; 13(5):792-800. PubMed ID: 24401748
[TBL] [Abstract][Full Text] [Related]
5. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.
McKeller RN; Fowler JL; Cunningham JJ; Warner N; Smeyne RJ; Zindy F; Skapek SX
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3848-53. PubMed ID: 11891301
[TBL] [Abstract][Full Text] [Related]
6. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
7. p19(Arf) limits primary vitreous cell proliferation driven by PDGF-B.
Iqbal NS; Devitt CC; Sung CY; Skapek SX
Exp Eye Res; 2016 Apr; 145():224-229. PubMed ID: 26778750
[TBL] [Abstract][Full Text] [Related]
8. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
9. Specific contribution of p19(ARF) to nitric oxide-dependent apoptosis.
Zeini M; Través PG; López-Fontal R; Pantoja C; Matheu A; Serrano M; Boscá L; Hortelano S
J Immunol; 2006 Sep; 177(5):3327-36. PubMed ID: 16920973
[TBL] [Abstract][Full Text] [Related]
10. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
Chen Z; Carracedo A; Lin HK; Koutcher JA; Behrendt N; Egia A; Alimonti A; Carver BS; Gerald W; Teruya-Feldstein J; Loda M; Pandolfi PP
Sci Signal; 2009 Aug; 2(84):ra44. PubMed ID: 19690330
[TBL] [Abstract][Full Text] [Related]
11. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
[TBL] [Abstract][Full Text] [Related]
12. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
13. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.
Martin AC; Thornton JD; Liu J; Wang X; Zuo J; Jablonski MM; Chaum E; Zindy F; Skapek SX
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3387-96. PubMed ID: 15452040
[TBL] [Abstract][Full Text] [Related]
15. An Arf(GFP/GFP) reporter mouse reveals that the Arf tumor suppressor monitors latent oncogenic signals in vivo.
Sherr CJ
Cell Cycle; 2004 Mar; 3(3):239-40. PubMed ID: 14726696
[TBL] [Abstract][Full Text] [Related]
16. p19ARF-induced p53-independent apoptosis largely occurs through BAX.
Suzuki H; Kurita M; Mizumoto K; Nishimoto I; Ogata E; Matsuoka M
Biochem Biophys Res Commun; 2003 Dec; 312(4):1273-7. PubMed ID: 14652011
[TBL] [Abstract][Full Text] [Related]
17. p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.
Sachs Z; Sharpless NE; DePinho RA; Rosenberg N
J Virol; 2004 Apr; 78(7):3304-11. PubMed ID: 15016851
[TBL] [Abstract][Full Text] [Related]
18. Decreased Mdm2 expression inhibits tumor development induced by loss of ARF.
Wang P; Greiner TC; Lushnikova T; Eischen CM
Oncogene; 2006 Jun; 25(26):3708-18. PubMed ID: 16491126
[TBL] [Abstract][Full Text] [Related]
19. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
20. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
